The expression of IL-1α by tumor cells is detected in 90% of the PDAC patients [9] and could correlate to mutations in the oncogene K-Ras as they also are present in up to 90% of the PDAC cases [25], [26], [27]. The gene discussed is KRAS; the disease is neoplasm.